We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > fluoxetine

News List

SSRIs Linked to Reduced Relative Risk for Mortality in COVID-19 Drugs
November 16, 2021
For patients with COVID-19, selective serotonin reuptake inhibitors (SSRIs) are associated with a reduced relative risk for mortality, according to a study published online Nov. 15 in JAMA Network Open.
COVID patients on SSRI antidepressants are less likely to die, UCSF-Stanford study finds FirstWordPharma
November 16, 2021
A large analysis of health records from 87 health care centers across the United States found that people taking a class of antidepressants called selective serotonin reuptake inhibitors (SSRIs)...
Aurobindo Pharma gets US FDA nod for generic antidepressant tablets expresspharma
April 13, 2020
Drug firm Aurobindo Pharma said that it has received the final nod from the US health regulator for its generic anti-depressant Fluoxetine tablets.